Zacks: Analysts Anticipate Oak Street Health, Inc. (NYSE:OSH) to Post -$0.47 EPS

Equities research analysts predict that Oak Street Health, Inc. (NYSE:OSHGet Rating) will announce earnings of ($0.47) per share for the current fiscal quarter, according to Zacks. Seven analysts have issued estimates for Oak Street Health’s earnings, with the highest EPS estimate coming in at ($0.33) and the lowest estimate coming in at ($0.51). Oak Street Health posted earnings per share of ($0.44) during the same quarter last year, which would indicate a negative year over year growth rate of 6.8%. The business is expected to report its next quarterly earnings report on Monday, January 1st.

According to Zacks, analysts expect that Oak Street Health will report full year earnings of ($2.20) per share for the current fiscal year, with EPS estimates ranging from ($2.29) to ($2.12). For the next financial year, analysts expect that the company will report earnings of ($1.62) per share, with EPS estimates ranging from ($1.92) to ($1.35). Zacks Investment Research’s EPS calculations are an average based on a survey of research firms that that provide coverage for Oak Street Health.

Oak Street Health (NYSE:OSHGet Rating) last posted its quarterly earnings results on Tuesday, May 3rd. The company reported ($0.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.39) by ($0.04). Oak Street Health had a negative return on equity of 413.94% and a negative net margin of 26.82%. The firm had revenue of $513.80 million for the quarter, compared to analysts’ expectations of $506.82 million. During the same period in the prior year, the company earned ($0.29) earnings per share. The company’s revenue for the quarter was up 73.2% on a year-over-year basis.

Several analysts have recently commented on the stock. Cowen upgraded shares of Oak Street Health from a “market perform” rating to an “outperform” rating and increased their price target for the company from $25.00 to $30.00 in a research report on Thursday, March 17th. Guggenheim assumed coverage on shares of Oak Street Health in a research note on Tuesday, March 29th. They set a “neutral” rating on the stock. Truist Financial reduced their price objective on shares of Oak Street Health from $45.00 to $34.00 in a research note on Wednesday, January 19th. SVB Leerink upped their price objective on shares of Oak Street Health from $17.00 to $23.00 and gave the company a “market perform” rating in a research note on Wednesday, March 2nd. Finally, Barclays upped their price objective on shares of Oak Street Health from $27.00 to $31.00 and gave the company an “overweight” rating in a research note on Tuesday, April 19th. Five analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $39.79.

Shares of OSH opened at $16.24 on Thursday. The company has a current ratio of 1.79, a quick ratio of 1.79 and a debt-to-equity ratio of 16.10. The firm’s 50-day moving average is $22.19 and its two-hundred day moving average is $25.61. Oak Street Health has a twelve month low of $13.29 and a twelve month high of $65.22. The firm has a market capitalization of $3.92 billion, a P/E ratio of -8.20 and a beta of 2.41.

In other Oak Street Health news, insider Geoffrey M. Price sold 60,000 shares of the business’s stock in a transaction dated Tuesday, May 3rd. The shares were sold at an average price of $18.91, for a total transaction of $1,134,600.00. Following the sale, the insider now directly owns 2,013,270 shares in the company, valued at approximately $38,070,935.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Brian Clem sold 15,000 shares of the business’s stock in a transaction dated Thursday, March 3rd. The stock was sold at an average price of $21.35, for a total transaction of $320,250.00. The disclosure for this sale can be found here. Insiders sold a total of 275,000 shares of company stock valued at $6,529,450 over the last ninety days. Company insiders own 11.40% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. CI Investments Inc. acquired a new stake in Oak Street Health in the third quarter valued at approximately $28,000. Benjamin Edwards Inc. raised its stake in Oak Street Health by 9,016.7% during the 1st quarter. Benjamin Edwards Inc. now owns 1,094 shares of the company’s stock valued at $29,000 after purchasing an additional 1,082 shares during the last quarter. Confluence Wealth Services Inc. acquired a new position in Oak Street Health during the 4th quarter valued at $34,000. Fifth Third Bancorp acquired a new position in Oak Street Health during the 1st quarter valued at $46,000. Finally, Canada Pension Plan Investment Board acquired a new position in Oak Street Health during the 4th quarter valued at $46,000. 91.42% of the stock is currently owned by hedge funds and other institutional investors.

Oak Street Health Company Profile (Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.

See Also

Get a free copy of the Zacks research report on Oak Street Health (OSH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.